Fosun International Limited

Fosun International Limited

FOSUF
Fosun International LimitedUS flagOther OTC
0.43
USD
-NaN
- -
3.50BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
7.93
9.18
10.39
8.6
10.27
12.77
16.76
16.12
19.33
22.07
24.25
23.62
21.35
Basic EPS, GAAP
0.86
1.02
1.06
1.19
1.54
1.57
1.73
0.94
1.21
-0.1
0.17
-0.53
-2.88
Free Cash Flow per Basic Share
-0.99
-0.13
-1.03
0.8
2.62
0.2
-0.1
-0.04
-1.47
-1.18
-0.41
1.92
1.9
Dividend per Share
0.03
0.32
0.07
0.28
0.14
0.12
0.26
0.18
0.11
0.43
- -
0.03
0.03
Book Value per Share
3.44
6.61
9.23
8.98
10.23
11.38
12.27
12.72
13.61
13.45
12.99
12.47
9.54
Tangible Book Value per Share
8.77
9.9
10.55
12.44
12.87
14.28
16.1
16.78
17.7
16.62
17.4
16.51
13.08
Basic Weighted Avg Shares
6,432
6,729
7,582
8,601
8,573
8,560
8,532
8,483
8,345
8,265
8,174
8,135
8,124
Sales/Revenue/Turnover
51,017
61,738
78,797
73,967
88,025
109,352
142,982
136,742
161,291
182,426
198,200
192,142
173,425
Operating Margin (%)
7.91
5.73
2.05
3.73
6.62
5.65
7.36
5.99
3.82
2.48
1.23
3.54
2.48
Depreciation Expense
1,741
2,309
3,747
3,177
2,685
3,828
6,698
7,504
7,926
9,007
10,557
10,709
11,540
Net Income, GAAP
5,519
6,854
8,038
10,268
13,161
13,406
14,801
8,000
10,085
-832
1,379
-4,349
-23,396
Effective Tax Rate (%)
19.55
24.55
32.31
22.08
26.88
22.66
26.7
34.65
30.7
71.97
32.07
746.9
- -
Profit Margin (%)
10.82
11.1
10.2
13.88
14.95
12.26
10.35
5.85
6.25
-0.46
0.7
-2.26
-13.49
Working Capital
4,251
12,476
11,512
43,099
16,160
43,285
11,333
17,849
-13,683
-5,864
1,730
-22,173
-15,530
LT Debt
40,223
51,180
68,189
84,804
93,945
122,688
137,913
154,310
131,892
120,640
137,036
124,484
142,003
Total Equity
61,300
75,684
99,553
122,874
136,412
160,441
180,924
193,085
199,609
199,075
208,575
197,539
168,296
Return on Invested Capital (%)
2.56
1.7
0.55
0.9
1.54
1.46
1.98
1.23
0.94
0.28
0.37
-9.67
- -
Return on Capital (%)
5.01
4.85
4.3
5.05
5.17
4.9
4.57
2.74
2.28
-0.41
1.33
-20.91
- -
Return on Common Equity (%)
27.75
20.58
14.05
13.95
15.97
14.49
14.65
7.53
9.11
-0.74
1.27
-4.19
-26.15

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.93%
-2.44%
-14.8%
Free Cash Flow
308.85%
670.9%
-1.22%
Net Income, GAAP
-30.31%
-65.07%
437.97%
Sales/Revenue/Turnover
9.04%
5.38%
-9.74%
Total Cash Common Dividend
112.19%
144.08%
-19.29%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
198,200
2024
- -
- -
- -
- -
192,142
2025
- -
- -
- -
- -
173,425

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.17
2024
- -
- -
- -
- -
-0.53
2025
- -
- -
- -
- -
-2.88

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
0.03
2025
- -
- -
- -
- -
0.03

Company Description

APIChat
CEO
Qiyu Chen
Full Time Employees
104,000
Sector
Industrials
Industry
Conglomerates
Address
Bund Finance Center Shanghai People's Republic of China 200010
IPO Date
Jan 5, 2010
Website
fosun.com
Business
Fosun International Limited functions as a global investment entity, providing quality offerings and solutions across health, lifestyle, financial services, and advanced manufacturing sectors in its primary markets of China and Portugal, alongside extensive international operations. The company organizes its diverse activities into four key divisions: Health, Happiness, Wealth, and Intelligent Manufacturing. Its Health division concentrates on the development, production, distribution, and commercialization of pharmaceutical and biotechnological products, along with delivering medical and wellness management services, notably advancing innovative treatments. The Happiness segment encompasses ventures and investments in the travel and leisure, fashion consumer, and broader lifestyle industries. Within the Wealth segment, operations include insurance provisions, comprehensive asset management, and strategic market investments. The Intelligent Manufacturing sector focuses on fostering smart production capabilities and deals with the output of iron, steel, new materials, and mineral resources. Additionally, the group engages in capital deployment, real estate development, retail, various banking and financial solutions, and digital innovation. Established in 1992, this Shanghai-headquartered enterprise operates as a subsidiary of Fosun Holdings Limited, actively expanding its global footprint with a strong emphasis on innovation.

Company News

APIChat
  • Creating a Sustainable Impact: Fosun International Releases 2025 ESG Report and Climate Information Disclosures Report

  • Fosun International Holds 2025 Annual Results Presentation: Fosun has the Ability to Navigate Through Cycles

  • Fosun International Receives "Certificate of Excellence in Environmental, Social and Governance Reporting" from Hong Kong Management Association

  • Fosun International Honored with Gold Award and Best Sustainability Team at The Asset Corporate Sustainability Leadership Awards 2025

  • Fosun Returns Leaner With An Attractive Valuation

  • Fosun International Recognized among Fortune's 2025 "Most Admired Chinese Companies" List

  • Hong Kong's Fosun to divest stake in Luz Saúde to Macquarie-linked firm

  • Fosun International Limited (FOSUF) Q4 2023 Earnings Call Transcript

  • Fosun International Included in S&P Global's Sustainability Yearbook 2024 and Recognized as Industry Mover

  • Fosun International Limited (FOSUF) Q2 2023 Earnings Call Transcript

  • Lanvin Nears Completion Of U.S. SPAC Listing. Now The Work Begins

  • China Offers Up Luxury Investment With Lanvin Backdoor Listing Plan

  • Fosun Fashion Group Forms Strategic Alliance with Baozun, Activation and Other Industry Partners to Capture Untapped Potential in Luxury Sector

  • Fosun International's (FOSUF) CEO Wei Bo on Q4 2020 Results - Earnings Call Transcript

  • Fosun Providing BioNtech's Covid 19-Vaccine The Keys To The East